EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
05/07/2025
Back to search
Official data from USPTO
FORMEDIX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
FORMEDIX
ST13
US500000090156971Class
35, 41, 42
Filing
90156971
Registration
6534013
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
05/14/2025
Trademark type
Word
Nice classes
35, 41, 42
Filing date
09/03/2020
Registration date
10/26/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/26/2021
Last transaction
05/14/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
99
Owner location
Glasgow, SC
Examiner
BURCH,JILLIAN RENEE
Law office
O10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Formedix Limited
Formedix Limited
Representatives
Carrie Webb Olson DAY PITNEY LLP
Technical classification
Nice Classes
Class 35Class 41Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
On-line retail ordering services featuring clinical metadata management computer software for use in relation to clinical trialsclinical management computer software for use in relation to clinical trialscomputer software for use in exclusively collectingstoringcontrollingmanaging and submitting of clinical metadata and clinical data in relation to clinical trialsdatabase management computer software for use exclusively in relation to clinical trialscomputer software to allow users to collectstorecontrolmanage and submit clinical metadata and clinical data in relation to clinical trialscomputer databases for collectingstoringcontrollingmanaging and submitting clinical data in relation to clinical trialscomputer software designed to ensure that clinical metadata and clinical data meets the regulations and standards required by international and government agencies in relation to clinical trialscomputer software used by pharmaceutical companiesbiotechnology companiesmedical device manufacturerscontract research organizations to help collect the required clinical data and meet the required standards for data collectiontabulationanalysissubmission for clinical trialsall of the aforesaid computer software being used in relation to clinical trials only
Class 41
Providing training services to enable pharmaceutical companiesbiotechnology companiesmedical device manufacturerscontract research organizations to use clinical metadata management software platforms for managing clinical trial metadata and clinical trial data; providing training services to enable pharmaceutical companiesbiotechnology companiesmedical device manufacturerscontract research organizations to collect the required clinical data and meet the regulations and standards required by international and government agencies for data collectiontabulationanalysissubmission for clinical trials; providing training services in relation to the use of clinical metadata management computer software for use in relation to clinical trials; providing training services in relation to the use of clinical management computer software for use in relation to clinical trials; all of the aforesaid training services being used in relation to clinical trials only
Class 42
Providing temporary use of on-line non-downloadable clinical metadata management computer software for use in relation to clinical trials; providing temporary use of on-line non-downloadable clinical management computer software for use in relation to clinical trials; providing temporary use of on-line non-downloadable computer software for use in exclusively collectingstoringcontrollingmanaging and submitting of clinical metadata and clinical data in relation to clinical trials; providing temporary use of on-line non-downloadable database management computer software for use exclusively in relation to clinical trials; providing temporary use of on-line non-downloadable computer software to allow users to collectstorecontrolmanage and submit clinical metadata and clinical data in relation to clinical trials; providing on-line computer databases for collectingstoringcontrollingmanaging and submitting clinical data in relation to clinical trials; providing temporary use of on-line non-downloadable computer software designed to ensure that clinical metadata and clinical data meets the regulations and standards required by international and government agencies in relation to clinical trials; providing temporary use of on-line non-downloadable computer software used by pharmaceutical companiesbiotechnology companiesmedical device manufacturerscontract research organizations to help collect the required clinical data and meet the required standards for data collectiontabulationanalysissubmission for clinical trials; design and development of computer software exclusively for managing clinical metadata and clinical data in clinical trials; designingcreating and maintaining web pages exclusively in connection with collectingstoringcontrolling and managing clinical metadata and clinical datato meet the regulations and standards required by international and government agencies in conducting clinical trials; all of the aforesaid software services being used in relation to clinical trials only; technical support servicestroubleshooting of computer software problems related to clinical metadata management software platforms for managing clinical trial metadata and clinical trial data; providing medical and scientific research information in the field of clinical trials to enable pharmaceutical companiesbiotechnology companiesmedical device manufacturerscontract research organizations to collect the required clinical data and meet the regulations and standards required by international and government agencies for data collectiontabulationanalysissubmission for clinical trials; technical support servicestroubleshooting of computer software problems related to clinical metadata management computer software for use in relation to clinical trials; technical support servicestroubleshooting of computer software problems related to clinical management computer software for use in relation to clinical trials; all of the aforesaid information and support services being used in relation to clinical trials only
Publications
History of USPTO decisions and trademark events.
32 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/07/2025
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
05/07/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/07/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/07/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/07/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/07/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
10/26/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/10/2021
PUBO
PUBLISHED FOR OPPOSITION
08/10/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/21/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/01/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
07/01/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/01/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
07/01/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/01/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/21/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/21/2021
ALIE
ASSIGNED TO LIE
06/17/2021
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
03/29/2021
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
03/25/2021
GNSL
LETTER OF SUSPENSION E-MAILED
03/25/2021
CNSL
SUSPENSION LETTER WRITTEN
03/25/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/04/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/03/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/03/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/22/2020
GNRT
NON-FINAL ACTION E-MAILED
12/22/2020
CNRT
NON-FINAL ACTION WRITTEN
12/22/2020
DOCK
ASSIGNED TO EXAMINER
12/21/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/08/2020
NWAP
NEW APPLICATION ENTERED
09/07/2020
Continuous trademark protection
Get notified about every new filing that threatens FORMEDIX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.